• 啟弘生物科技(TFBS Bioscience)與日本帝人集團(Teijin)、日本Mediridge公司進行台日再生醫療CDMO結盟

  2023-03-28 啟弘生物科技(TFBS Bioscience)與日本帝人集團(Teijin)、日本Mediridge公司進行台日再生醫療CDMO結盟 台北時間 2023 年 3 月 28 日——啟弘生物科技(TFBS Bioscience Inc.)與日本帝人公司(Teijin Limited)，及日本Mediridge Co., Ltd. 今天宣布，將共同為細胞和基因治療產品提供病毒載體和質粒，用於開發和製造基因編輯的再生醫療產品。 Learn more

• EXCITING NEWS IN GMP TESTING SERVICES

  2023-11-26 EXCITING NEWS IN GMP TESTING SERVICES Learn more

• TFBS Bioscience Complete its First Clinical-Grade Manufacturing Batch of Lentiviral Vectors for CAR-T Cell Therapy in Taiwan

  2022-08-17 TFBS Bioscience Complete its First Clinical-Grade Manufacturing Batch of Lentiviral Vectors for CAR-T Cell Therapy in Taiwan - A critical step for TFBS Bioscience to enable the manufacturing of clinical-grade lentiviral vectors in its Taipei facility and ready to supply viral vectors for the global needs of cell and gene therapies Learn more

• Meet TFBS in BIO2022

  2022-05-09 Meet TFBS in BIO2022 TFBS team will be at #BIO2022 in San Diego, June 13-16! (Hall D #3323 in Taiwan Pavilion). Looking forward to catching up in person and making new connections on all! Learn more

• Center for Drug Evaluation (CDE) to visit TFBS Bioscience, Inc.

  2022-04-29 Center for Drug Evaluation (CDE) to visit TFBS Bioscience, Inc. We are honored to invite the Center for Drug Evaluation (CDE) to visit TFBS Bioscience, Inc. GMP viral vector manufacturing facility. Learn more